Program

October 27–30 | Walter E. Washington Convention Center | Washington, D.C.

Late-Breaking Research

Witness First-Time Presentations of Major Clinical Trials and Impactful Science Research

Get a front-row seat to the latest breakthroughs that will change your practice and redefine patient care globally.

VIEW PROGRAM GUIDE

Early TAVR
Transcatheter Aortic Valve Replacement for Asymptomatic Severe Aortic Stenosis: Results of the EARLY TAVR Trial

Philippe Genereux
EVOLVED
Early Intervention in Patients With Asymptomatic Severe Aortic Stenosis and Left Ventricular Myocardial Fibrosis

Marc Dweck
TAVR UNLOAD
Transcatheter Aortic Valve Replacement in Patients With Systolic Heart Failure and Moderate Aortic Stenosis

Nicholas M. Van Mieghem
ECLIPSE
A Large-Scale, Randomized Trial of Orbital Atherectomy vs. Conventional Balloon Angioplasty in Severely Calcified Coronary Arteries Prior to DES Implantation

Ajay J. Kirtane
CLEAR SYNERGY (OASIS 9)
A 2x2 Factorial Randomized Controlled Trial of Colchicine Versus Placebo and Spironolactone Versus Placebo in Patients With Myocardial Infarction: The Results of the Colchicine Factorial

Sanjit S. Jolly
PEERLESS
Large-Bore Mechanical Thrombectomy vs Catheter-directed Thrombolysis for Treatment of Intermediate-Risk Pulmonary Embolism

Wissam A. Jaber
SIRONA
Head-to-Head Comparison of Sirolimus- Versus Paclitaxel-Coated Balloon Angioplasty in the Femoropopliteal Artery

Ulf Teichgraeber
TRISCEND II
Randomized Comparison of Transcatheter Valve Replacement vs. Optimal Medical Therapy for Severe Tricuspid Regurgitation

Susheel K. Kodali / Suzanne V. Arnold
FAVOR III Europe
Quantitative Flow Ratio or Fractional Flow Reserve for Guiding Coronary Revascularization

Birgitte Krogsgaard Andersen
FLASH
Artificial Intelligence-Based Fully Automated Quantitative Coronary Angiography Versus Optical Coherence Tomography Guidance for Coronary Stent Implantation: A Multicenter, Randomized Controlled Non-Inferiority Trial

Jung-Min Ahn
ACURATE IDE
One-year Outcomes of ACURATE neo2 vs Approved TAVR Devices in All-risk patients with Severe AS: the ACURATE IDE Trial

Michael J. Reardon
Loading...

Join The Conversation #TCT2024

CRF Logo

Sign Up for Our Newsletter

Get the latest news and information from CRF.

By submitting your email address, you agree to CRF's Privacy Policy & Terms and Conditions.

1700 Broadway, 9th Floor
New York, NY 10019
646.434.4500
[email protected]

© 2024, Cardiovascular Research Foundation®. All rights reserved.

Privacy Policy
Terms and Conditions of Use